IRVINE, Calif., July 18, 2024 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (“Nymox”) (OTC Markets NYMXF) announced today that its Annual Report is and has been in progress since late...
IRVINE, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (“Nymox”) (OTC Markets NYMXF) announced today that its MAA submission to the Danish Medicines Agency (DKMA) has run...
IRVINE, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nymox) (OTC Markets - NYMXF) is pleased to report that the Bahamas Supreme Court has issued a formal Order...
IRVINE, Calif., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nymox) (OTC Markets NYMXF) is pleased to provide this end-of-the year message to shareholders. The Company has...
The Nymox Pharmaceutical versus AscellaHealth drama has heightened, with the battle heading to court as Nymox seeks $250 million in damages.
IRVINE, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- This week, Nymox Pharmaceutical Corporation (œNymox) (OTC Markets - NYMXF) was forced to file a lawsuit in California Superior Court, Orange...
The Committee to Restore Nymox Shareholder Value Provides Factual Update
Ex-Employees and Agents, and those working in concert with them, are ordered by a California Court to stop using, disclosing, relying on, or otherwise make publicly available Nymox privileged...
IRVINE, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (œNymox or theœCompany) [OTC Markets---NYMXF] is pleased to announce that the Bahamian Court (Senior Justice...
IMPORTANT MESSAGE TO NYMOX SHAREHOLDERS: NYMOX Cautions Against Unauthorized Improper Shareholder Meeting and Unauthorized Unregistered Solicitations